1. How low can you go…
Speculation on the impact of GLP-1s, or weight loss drugs, on all facets of daily life has been rife. But a lot of uncertainties remain to be worked through. At their result this week, Resmed provided their analysis of the impact of these drugs on their total addressable market (TAM) for sleep devices. Resmed estimates that out to 2050, GLP-1s may impact their potential TAM by ~14%. So instead of a potential population of 1.4 billion patients, this may reduce to 1.2 billion patients.
Resmed have sold around 22.5 million devices to date, and so even with a lower addressable market there remains significant headroom for growth to continue at or above historic rates. Resmed’s CEO, Mick Farrell, commented that they “are not seeing any significant change in the adherence rates” on their sleep device machines, but rather they are “seeing the number of new patients activated into the health care funnel picking up”. We continue to monitor this space!
Source: ResMed (October 2023)
2. The price is high…
Firetrail S3 Global Opportunities Fund holding Chubb released a strong 3Q result this week. Management remain disciplined in underwriting, and the operating backdrop remains supportive. In particular, Chubb have continued pushing price in their North American business as shown in the green bars below. This provides a good read through for the North American business of High Conviction Fund holding QBE as well.
Source: Chubb, Firetrail (October 2023)
Companies mentioned are illustrative only and not a recommendation to buy or sell any particular security.
3. Surprise sales…
We continue to be amazed at just how strong retailers remain, despite the cost-of-living pressures. BCF and Nick Scali on the right of the chart below had surprisingly strong August/September periods. The November 7 interest rate decision looms large as it comes two weeks before Black Friday sales are set to start. Although we have seen some very early promotional activity starting already…
Non-food retailer YoY sales growth
Source: Barrenjoey, Company data (October 2023)